Cystatin C and Creatinine in an HIV Cohort: the Nutrition for Healthy Living Study

Overview

Journal Am J Kidney Dis

Specialty Nephrology

Date 2008 May 6

PMID 18455851

Citations 23

Authors

Clara Y Jones

Camille A Jones

Ira B Wilson

Tamsin A Knox

Andrew S Levey

Donna Spiegelman

Sherwood L Gorbach

Frederick Van Lente

Lesley A Stevens

Affiliations

Soon will be listed here.

Abstract

Background: Human immunodeficiency virus (HIV)-infected persons have an increased risk of chronic kidney disease (CKD). Serum creatinine level may underestimate the prevalence of CKD in subjects with decreased lean body mass or liver disease. Level of serum cystatin C, an alternative kidney function marker, is independent of lean body mass.

Study Design: Cross-sectional.

Setting & Participants: 250 HIV-infected subjects on highly active antiretroviral therapy in the Nutrition for Healthy Living (NFHL) cohort; 2,628 National Health and Nutrition Examination Survey (NHANES) 2001-2002 subjects.

Predictors & Outcomes: Comparison of serum creatinine levels in NFHL to those in NHANES subjects; comparison of CKD in NFHL subjects ascertained using serum creatinine versus cystatin C levels.

Measurements: Standardized serum creatinine, serum cystatin C, glomerular filtration rate (GFR) estimated from serum creatinine and cystatin C levels.

Results: Creatinine levels were lower in NFHL than NHANES subjects despite greater rates of hepatitis, diabetes, and drug use (mean difference, -0.18 mg/dL; P < 0.001 adjusted for age, sex, and race). Of NFHL subjects, only 2.4% had a creatinine-based estimated GFR less than 60 mL/min/1.73 m(2), but 15.2% had a cystatin-based estimated GFR less than 60 mL/min/1.73 m(2).

Limitations: GFR was estimated rather than measured. Other factors in addition to GFR may affect creatinine and cystatin C levels. Measurements of proteinuria were not available.

Conclusions: Serum creatinine levels may overestimate GFRs in HIV-infected subjects. Kidney disease prevalence may be greater than previously appreciated.

Citing Articles

Changes in the immunohistochemical expression of nephrin protein in renal corpuscle of rats in response to sleep disturbance.

Mohsin Z, Kamoona H J Mol Histol. 2025; 56(2):88.

PMID: 39953244 DOI: 10.1007/s10735-025-10372-z.

A Comparison of Creatinine, Cystatin C, and Creatinine-Cystatin C Based Equations in HIV/AIDS Patients: A Cross-Sectional Study.

Ampiah K, Afari R, Osei-Assibey J, Asamoah R, Acheampong A, Dzata L Health Sci Rep. 2024; 7(12):e70263.

PMID: 39669187 PMC: 11635174. DOI: 10.1002/hsr2.70263.

A systematic review assessing the potential use of cystatin c as a biomarker for kidney disease in people living with HIV on antiretroviral therapy.

Hanser S, Choshi J, Mokoena H, Mabhida S, Mchiza Z, Moetlediwa M Front Med (Lausanne). 2024; 11:1295217.

PMID: 38566923 PMC: 10985183. DOI: 10.3389/fmed.2024.1295217.

The prevalence of renal impairment in individuals seeking HIV testing in Urban Malawi.

Glaser N, Phiri S, Bruckner T, Nsona D, Tweya H, Ahrenshop N BMC Nephrol. 2016; 17(1):186.

PMID: 27875991 PMC: 5118906. DOI: 10.1186/s12882-016-0403-7.

Comparison of Various Equations for Estimating GFR in Malawi: How to Determine Renal Function in Resource Limited Settings?.

Glaser N, Deckert A, Phiri S, Rothenbacher D, Neuhann F PLoS One. 2015; 10(6):e0130453.

PMID: 26083345 PMC: 4470826. DOI: 10.1371/journal.pone.0130453.

References

Marras D, Bruggeman L, Gao F, Tanji N, Mansukhani M, Cara A . Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med. 2002; 8(5):522-6. DOI: 10.1038/nm0502-522. View

Villa P, Jimenez M, Soriano M, Manzanares J, Casasnovas P . Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care. 2005; 9(2):R139-43. PMC: 1175926. DOI: 10.1186/cc3044. View

Vinge E, Lindergard B, Nilsson-Ehle P, Grubb A . Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest. 2000; 59(8):587-92. DOI: 10.1080/00365519950185076. View

Massey D . Commentary: clinical diagnostic use of cystatin C. J Clin Lab Anal. 2004; 18(1):55-60. PMC: 6808083. DOI: 10.1002/jcla.10098. View

Coresh J, Astor B, McQuillan G, Kusek J, Greene T, Van Lente F . Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002; 39(5):920-9. DOI: 10.1053/ajkd.2002.32765. View

Levey A, Coresh J, Greene T, Stevens L, Zhang Y, Hendriksen S . Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145(4):247-54. DOI: 10.7326/0003-4819-145-4-200608150-00004. View

Stevens L, Coresh J, Greene T, Levey A . Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med. 2006; 354(23):2473-83. DOI: 10.1056/NEJMra054415. View

Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A . Cystatin C as a marker of GFR--history, indications, and future research. Clin Biochem. 2004; 38(1):1-8. DOI: 10.1016/j.clinbiochem.2004.09.025. View

Randers E, Ivarsen P, Erlandsen E, Hansen E, Aagaard N, Bendtsen F . Plasma cystatin C as a marker of renal function in patients with liver cirrhosis. Scand J Clin Lab Invest. 2002; 62(2):129-34. DOI: 10.1080/003655102753611753. View

10.

Samyn M, Cheeseman P, Bevis L, Taylor R, Samaroo B, Buxton-Thomas M . Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl. 2005; 11(3):344-9. DOI: 10.1002/lt.20330. View

11.

Conaldi P, Biancone L, Bottelli A, Wade-Evans A, Racusen L, Boccellino M . HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest. 1998; 102(12):2041-9. PMC: 509158. DOI: 10.1172/JCI3480. View

12.

Galteau M, Guyon M, Gueguen R, Siest G . Determination of serum cystatin C: biological variation and reference values. Clin Chem Lab Med. 2001; 39(9):850-7. DOI: 10.1515/CCLM.2001.141. View

13.

Gupta S, Eustace J, Winston J, Boydstun I, Ahuja T, Rodriguez R . Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005; 40(11):1559-85. DOI: 10.1086/430257. View

14.

Tan G, Lewis A, James T, Altmann P, Taylor R, Levy J . Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care. 2002; 25(11):2004-9. DOI: 10.2337/diacare.25.11.2004. View

15.

Randers E, Erlandsen E, Pedersen O, Hasling C, Danielsen H . Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol. 2000; 54(3):203-9. View

16.

Knight E, Verhave J, Spiegelman D, Hillege H, de Zeeuw D, Curhan G . Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004; 65(4):1416-21. DOI: 10.1111/j.1523-1755.2004.00517.x. View

17.

Larsson A, Malm J, Grubb A, Hansson L . Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest. 2004; 64(1):25-30. DOI: 10.1080/00365510410003723. View

18.

Kotler D . Nutritional alterations associated with HIV infection. J Acquir Immune Defic Syndr. 2000; 25 Suppl 1:S81-7. DOI: 10.1097/00042560-200010001-00013. View

19.

Levey A, Coresh J, Greene T, Marsh J, Stevens L, Kusek J . Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007; 53(4):766-72. DOI: 10.1373/clinchem.2006.077180. View

20.

Orlando R, Mussap M, Plebani M, Piccoli P, De Martin S, Floreani M . Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem. 2002; 48(6 Pt 1):850-8. View